| Mr Daniel Vincent Mcelroy, FNP-C | |
|
1508 Genesee St Ste 1, Utica, NY 13502-5178 | |
| (315) 798-8737 | |
| Not Available |
| Full Name | Mr Daniel Vincent Mcelroy |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1508 Genesee St Ste 1, Utica, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104311844 | NPI | - | NPPES |
| 343182 | Other | NY | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 343182 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Faxton-st Luke's Healthcare | Utica, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Faxton-st Lukes Healthcare | 2769380252 | 291 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
"Tens of thousands of people uprooted or trapped by conflict in northern Mali are going without enough food, leading to a spike in cases of children suffering from malnutrition, medical aid groups say," AlertNet reports.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in the US have been rising rapidly over the last 30 years, and although scientists have managed to identify key risk factors, melanoma's modus operandi has eluded the world of medical research.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.
SelectHealth is pleased to announce the recipients of the 2012 Select 25 award. The nonprofit health insurance carrier will give $2,500 to each of the 25 winners to assist them in their efforts to improve health and wellness, or to serve populations with special needs.
› Verified 2 days ago
| Entity Name | Faxton-st Lukes Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770690737 PECOS PAC ID: 2769380252 Enrollment ID: O20031222000433 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
"Tens of thousands of people uprooted or trapped by conflict in northern Mali are going without enough food, leading to a spike in cases of children suffering from malnutrition, medical aid groups say," AlertNet reports.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in the US have been rising rapidly over the last 30 years, and although scientists have managed to identify key risk factors, melanoma's modus operandi has eluded the world of medical research.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.
SelectHealth is pleased to announce the recipients of the 2012 Select 25 award. The nonprofit health insurance carrier will give $2,500 to each of the 25 winners to assist them in their efforts to improve health and wellness, or to serve populations with special needs.
› Verified 2 days ago
| Entity Name | Primary Care Metabolic Disorders Medical Practice Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942833835 PECOS PAC ID: 5799116737 Enrollment ID: O20200507002164 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
"Tens of thousands of people uprooted or trapped by conflict in northern Mali are going without enough food, leading to a spike in cases of children suffering from malnutrition, medical aid groups say," AlertNet reports.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in the US have been rising rapidly over the last 30 years, and although scientists have managed to identify key risk factors, melanoma's modus operandi has eluded the world of medical research.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.
SelectHealth is pleased to announce the recipients of the 2012 Select 25 award. The nonprofit health insurance carrier will give $2,500 to each of the 25 winners to assist them in their efforts to improve health and wellness, or to serve populations with special needs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Daniel Vincent Mcelroy, FNP-C 109 Thurston Ter, Sherrill, NY 13461-1278 Ph: (315) 725-3698 | Mr Daniel Vincent Mcelroy, FNP-C 1508 Genesee St Ste 1, Utica, NY 13502-5178 Ph: (315) 798-8737 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
"Tens of thousands of people uprooted or trapped by conflict in northern Mali are going without enough food, leading to a spike in cases of children suffering from malnutrition, medical aid groups say," AlertNet reports.
Skin cancer is the most common of all cancers, and melanoma, which accounts for 2% of skin cancer cases, is responsible for nearly all skin cancer deaths. Melanoma rates in the US have been rising rapidly over the last 30 years, and although scientists have managed to identify key risk factors, melanoma's modus operandi has eluded the world of medical research.
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH), announces awards to eight academic research centers to conduct collaborative studies of urologic chronic pelvic pain disorders by looking for clues outside the bladder and prostate. The total research investment for the five-year project is estimated to be up to $37.5 million.
SelectHealth is pleased to announce the recipients of the 2012 Select 25 award. The nonprofit health insurance carrier will give $2,500 to each of the 25 winners to assist them in their efforts to improve health and wellness, or to serve populations with special needs.
› Verified 2 days ago
Sarah Dunham, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1650 Champlin Ave, Utica, NY 13502 Phone: 315-624-8400 | |
Cynthia A Altieri, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1400 Noyes St, Utica, NY 13502 Phone: 315-797-6800 | |
Thet Thet Mar, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 120 Hobart St, Utica, NY 13501 Phone: 315-798-1149 Fax: 315-734-3565 | |
Barbara Jean Drake, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2211 Genesee St Ste 200, Utica, NY 13501 Phone: 315-733-7598 Fax: 315-733-7694 | |
Michael S Babula, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1001 Noyes St, Utica, NY 13502 Phone: 315-624-9471 Fax: 315-922-9502 | |
Vicki A. Haines, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1656 Champlin Ave, Suite 203, Utica, NY 13502 Phone: 315-738-0647 Fax: 315-738-9719 | |
Mrs. Susan Mary Kolb, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: Digestive Disease Medicine Of Cny, Llp, 116 Business Park Drive, 1st Floor, Utica, NY 13502 Phone: 315-624-7000 Fax: 315-793-1129 |